Scott GK - Search Results

1

Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.

Bons J, Tadeo A, Scott GK, Teramayi F, Tanner JJ, Schilling B, Benz CC, Ellerby LM. Bons J, et al. Among authors: scott gk. Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166848. doi: 10.1016/j.bbadis.2023.166848. Epub 2023 Aug 14. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 37586438 Free PMC article.

2

Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.

Scott GK, Marden C, Xu F, Kirk L, Benz CC. Scott GK, et al. Mol Cancer Ther. 2002 Apr;1(6):385-92. Mol Cancer Ther. 2002. PMID: 12477051

3

Essential cysteine-alkylation strategies to monitor structurally altered estrogen receptor as found in oxidant-stressed breast cancers.

Meza JE, Scott GK, Benz CC, Baldwin MA. Meza JE, et al. Among authors: scott gk. Anal Biochem. 2003 Sep 1;320(1):21-31. doi: 10.1016/s0003-2697(03)00296-3. Anal Biochem. 2003. PMID: 12895466

4

Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U, Benz CC. Zhou Y, et al. Among authors: scott gk. Int J Biochem Cell Biol. 2005 May;37(5):1130-44. doi: 10.1016/j.biocel.2004.09.006. Int J Biochem Cell Biol. 2005. PMID: 15743683

5

Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.

Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC. Drummond DC, et al. Clin Cancer Res. 2005 May 1;11(9):3392-401. doi: 10.1158/1078-0432.CCR-04-2445. Clin Cancer Res. 2005. PMID: 15867240

6

Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation.

Scott GK, Atsriku C, Kaminker P, Held J, Gibson B, Baldwin MA, Benz CC. Scott GK, et al. Mol Pharmacol. 2005 Sep;68(3):606-15. doi: 10.1124/mol.105.013474. Epub 2005 Jun 6. Mol Pharmacol. 2005. PMID: 15939799

7

Reactivity of zinc finger cysteines: chemical modifications within labile zinc fingers in estrogen receptor.

Atsriku C, Scott GK, Benz CC, Baldwin MA. Atsriku C, et al. Among authors: scott gk. J Am Soc Mass Spectrom. 2005 Dec;16(12):2017-26. doi: 10.1016/j.jasms.2005.08.009. Epub 2005 Oct 24. J Am Soc Mass Spectrom. 2005. PMID: 16246571 Free article.

8

Rapid alteration of microRNA levels by histone deacetylase inhibition.

Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Scott GK, et al. Cancer Res. 2006 Feb 1;66(3):1277-81. doi: 10.1158/0008-5472.CAN-05-3632. Cancer Res. 2006. PMID: 16452179 Free article.

9

Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription.

Marx C, Berger C, Xu F, Amend C, Scott GK, Hann B, Park JW, Benz CC. Marx C, et al. Among authors: scott gk. Assay Drug Dev Technol. 2006 Jun;4(3):273-84. doi: 10.1089/adt.2006.4.273. Assay Drug Dev Technol. 2006. PMID: 16834533

10

Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers.

Benz CC, Fedele V, Xu F, Ylstra B, Ginzinger D, Yu M, Moore D, Hall RK, Wolff DJ, Disis ML, Eppenberger-Castori S, Eppenberger U, Schittulli F, Tommasi S, Paradiso A, Scott GK, Albertson DG. Benz CC, et al. Among authors: scott gk. Genes Chromosomes Cancer. 2006 Nov;45(11):983-94. doi: 10.1002/gcc.20364. Genes Chromosomes Cancer. 2006. PMID: 16883574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters